Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet

Clinical trial NCT05886933 · COMPLETED

Trial details

NCT number: NCT05886933
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: COMPLETED
Study type: OBSERVATIONAL

Gastroesophageal Reflux Disease

Start date: 2023-05-22
Primary completion: 2024-04-30
Enrollment: 9846

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.